Intelligent Nanomedicine: AI-Driven Smart Carrier Design for Precision Skin Cancer Therapy

Area of Science:

• Oncology
• Nanomedicine
• Artificial Intelligence

Background:

• Skin cancer presents therapeutic challenges including poor drug penetration, systemic toxicity, and recurrence.
• Nanomedicine offers targeted, localized, and controlled drug delivery to overcome these limitations.
• Artificial Intelligence (AI) integration is revolutionizing nanocarrier design and optimization.

Purpose of the Study:

• To review the role of AI in designing, optimizing, and personalizing nanocarriers for skin cancer therapy.
• To highlight AI-driven strategies for overcoming therapeutic hurdles in skin cancer treatment.
• To emphasize the shift towards predictive, data-driven nanomedicine development.

Main Methods:

• Review of AI algorithms (machine learning, deep learning) for predicting drug-nanocarrier interactions.
• Analysis of AI applications in optimizing particle characteristics for dermal penetration and release kinetics.
• Exploration of AI in facilitating combination therapies and personalized treatment strategies.

Main Results:

• AI enables predictive design and optimization of smart nanocarriers for enhanced skin cancer treatment.
• AI facilitates combination therapies (chemo-, immuno-, photodynamic) for synergistic effects against resistant cancers.
• AI-driven personalization of nanomedicine based on patient data enhances safety and efficacy.

Conclusions:

• The convergence of AI and nanomedicine marks a paradigm shift in precision oncology for skin cancer.
• AI-guided nanocarrier development offers a powerful approach to address limitations in current skin cancer therapies.
• Further research is needed to address data quality, model validation, and regulatory aspects of AI-driven nanomedicine.